How has the migraine drugs market evolved, and where is it heading next?
The migraine drugs market size has grown strongly in recent years. It will grow from $5.38 billion in 2024 to $5.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to advancements in drug formulations, increased awareness and diagnosis, stress and lifestyle factors, expansion of generic drugs, emergence of cgrp inhibitors.
The migraine drugs market size is expected to see strong growth in the next few years. It will grow to $7.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to personalized medicine approaches, telemedicine and remote consultations, healthcare policy and insurance coverage, increasing global migraine burden, combination therapies. Major trends in the forecast period include targeted therapies, telemedicine and remote consultations, patient-centric approaches, digital therapeutics, biosimilars in migraine treatment, clinical research and trials.
Get Your Free Sample of The Global Migraine Drugs Market Report:
Migraine Drugs Market Report 2025, Research And Forecast Sample
Which major factors have contributed to the expansion of the migraine drugs market?
The growing female population is expected to propel the growth of the migraine drugs market going forward. The female population refers to the total number of females in all age groups who are residents in each country or region during a specific period. The prevalence of migraines is significantly higher in the female population compared to males due to a combination of genetic, hormonal, and environmental factors. For instance, in 2022, according to the World Population Prospects 2022 shared by the United Nations, a US-based intergovernmental organization, the population of females in the world is estimated at 4.00 billion, representing 49.75% of the world population, and it is now expected that females will outnumber males by 2049. Therefore, the growing female population is driving the growth of the migraine drugs market.
How is the migraine drugs market segmented?
The migraine drugs market covered in this report is segmented –
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Subsegments:
1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan
2) By Beta Blockers: Propranolol, Metoprolol, Timolol
3) By Angiotensin Blockers: Candesartan, Losartan
4) By Tricyclics: Amitriptyline, Nortriptyline
5) By Anticonvulsants: Topiramate, Valproate
Order your report now for swift delivery
Migraine Drugs Market Report 2025, Research And Forecast
Who are the top competitors in the migraine drugs market?
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy’s Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
Which key trends are expected to influence the migraine drugs market in the coming years?
Major companies operating in the migraine drugs market are focused on developing innovative products, such as Zavzpret, to better serve patients and gain a competitive edge in the market. Zavzpret is a nasal spray medication developed for the acute treatment of migraines with or without aura in adults. For instance, in March 2023, Pfizer, a US-based pharmaceutical company, received approval from the Food and Drug Administration, a US-based federal agency, for Zavzpret. It is the first and only approved zavegepant (CGRP receptor antagonist) nasal spray for the acute treatment of migraine. It targets the calcitonin gene-related peptide (CGRP) and is designed for the acute treatment of migraine. The approval of Zavzpret provides a new treatment option for individuals with migraines, especially for those who have nausea and vomiting with migraine attacks and for those who can’t use triptans because of cardiovascular risks.
Which regional trends are influencing the migraine drugs market, and which area dominates the industry?
North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Migraine Drugs Market Report 2025 Offer?
The migraine drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Migraine drugs refer to medications used to treat a kind of neurological illness in which a person experiences a sharp, throbbing headache. They function by focusing on different physiological mechanisms that cause migraines.
Purchase the exclusive report now to unlock valuable market insights:
Migraine Drugs Market Report 2025, Research And Forecast
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Analyzing the Future of Marble Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities – Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports – By The Business Research Company
Global Market Model: Global Market Intelligence Database
